These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30892942)

  • 1. High-throughput hydrogen bond strength calculation and its applications in optimizing drug ADME properties.
    Shen J; Yang Y; Broughton H; Watson IA; Desai PV
    Future Med Chem; 2019 Mar; 11(6):511-524. PubMed ID: 30892942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2010 Jun; 1(6):435-49. PubMed ID: 22778837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive computational assessment of ADME properties using mapping techniques.
    Balakin KV; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Ekins S
    Curr Drug Discov Technol; 2005 Jun; 2(2):99-113. PubMed ID: 16472234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Potential P-gp Substrates: Main Aspects to Choose the Adequate Permeability Model for Assessing Gastrointestinal Drug Absorption.
    da Silva Junior JB; Dezani TM; Dezani AB; dos Reis Serra CH
    Mini Rev Med Chem; 2015; 15(10):858-71. PubMed ID: 25963568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.
    Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH
    Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 model.
    Shah D; Paruchury S; Matta M; Chowan G; Subramanian M; Saxena A; Soars MG; Herbst J; Haskell R; Marathe P; Mandlekar S
    Drug Metab Lett; 2014; 8(2):109-18. PubMed ID: 25429513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein recognition of substrates and circumvention through rational drug design.
    Raub TJ
    Mol Pharm; 2006; 3(1):3-25. PubMed ID: 16686365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite Cryptosporidium.
    Arnold SLM; Choi R; Hulverson MA; Whitman GR; Mccloskey MC; Dorr CS; Vidadala RSR; Khatod M; Morada M; Barrett LK; Maly DJ; Yarlett N; Van Voorhis WC
    J Infect Dis; 2019 Aug; 220(7):1188-1198. PubMed ID: 31180118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining P-gp efflux kinetics guided by the BDDCS - Rational selection of in vitro assay designs and mathematical models.
    Riede J; Umehara KI; Schweigler P; Huth F; Schiller H; Camenisch G; Poller B
    Eur J Pharm Sci; 2019 Apr; 132():132-141. PubMed ID: 30857914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier.
    Shen J; Cross ST; Tang-Liu DD; Welty DF
    Pharm Res; 2003 Sep; 20(9):1357-63. PubMed ID: 14567628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.
    Hochman JH; Yamazaki M; Ohe T; Lin JH
    Curr Drug Metab; 2002 Jun; 3(3):257-73. PubMed ID: 12083320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability--in vitro assays for assessing drug transporter activity.
    Jin H; Di L
    Curr Drug Metab; 2008 Nov; 9(9):911-20. PubMed ID: 18991588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B; Mohr P; Stahl M
    J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QM Implementation in Drug Design: Does It Really Help?
    Liu J; He X
    Methods Mol Biol; 2020; 2114():19-35. PubMed ID: 32016884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico, in vitro and in situ models to assess interplay between CYP3A and P-gp.
    Mudra DR; Desino KE; Desai PV
    Curr Drug Metab; 2011 Oct; 12(8):750-73. PubMed ID: 21568936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational Searching with Quantum Mechanics.
    Habgood M; James T; Heifetz A
    Methods Mol Biol; 2020; 2114():207-229. PubMed ID: 32016896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.